<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11547</article-id><article-id pub-id-type="doi">10.36691/RJA11547</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Clinical and immunological characteristics of food allergy in different forms of inherited epidermolysis bullosa</article-title><trans-title-group xml:lang="ru"><trans-title>Клинические и иммунологические особенности пищевой аллергии при различных формах врождённого буллёзного эпидермолиза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6701-3872</contrib-id><contrib-id contrib-id-type="spin">2960-6185</contrib-id><name-alternatives><name xml:lang="en"><surname>Galimova</surname><given-names>Albina A.</given-names></name><name xml:lang="ru"><surname>Галимова</surname><given-names>Альбина Альбертовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>albina86@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3056-403X</contrib-id><contrib-id contrib-id-type="spin">2094-2840</contrib-id><name-alternatives><name xml:lang="en"><surname>Makarova</surname><given-names>Svetlana G.</given-names></name><name xml:lang="ru"><surname>Макарова</surname><given-names>Светлана Геннадиевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><email>sm27@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2252-8570</contrib-id><contrib-id contrib-id-type="spin">5906-9724</contrib-id><name-alternatives><name xml:lang="en"><surname>Murashkin</surname><given-names>Nikolay N.</given-names></name><name xml:lang="ru"><surname>Мурашкин</surname><given-names>Николай Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>m_nn2001@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Medical Research Center for Children’s Health</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр здоровья детей</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет имени М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">The First Sechenov Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Central State Medical Academy of Department of Presidential Affairs</institution></aff><aff><institution xml:lang="ru">Центральная государственная медицинская академия Управления делами Президента Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-09-25" publication-format="electronic"><day>25</day><month>09</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-10-18" publication-format="electronic"><day>18</day><month>10</month><year>2023</year></pub-date><volume>20</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>299</fpage><lpage>308</lpage><history><date date-type="received" iso-8601-date="2023-05-24"><day>24</day><month>05</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-09-08"><day>08</day><month>09</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Фармарус Принт Медиа</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-10-18"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/11547">https://rusalljournal.ru/raj/article/view/11547</self-uri><abstract xml:lang="en"><p><bold><italic>BACKGROUND</italic></bold><italic>:</italic> Inherited epidermolysis bullosa is a severe orphan hereditary disease with a predominant lesion of the skin and mucous membranes. The study of the comorbid background, including food allergies, remains an urgent issue, given the difficulties that often arise in the treatment and formation of the diet in this category of patients.</p> <p><bold><italic>AIM</italic></bold><italic>:</italic> to assess the frequency and nature of food allergies in children with inherited epidermolysis bullosa.</p> <p><bold><italic>MATERIALS AND METHODS</italic></bold><italic>:</italic> An open single-center randomized observational retrospective and prospective study included 165 patients aged 2 months to 17 years with an inherited epidermolysis bullosa. All patients were evaluated for an allergic history, determination of the levels of total IgE and allergen-specific serum IgE to the most significant food allergens (UniCAP System, Thermo Fisher Scientific), if necessary, a diagnostic elimination diet and diagnostic product administration were prescribed, based on the data obtained, the diagnosis of food allergy was confirmed or excluded.</p> <p><bold><italic>RESULTS</italic></bold><italic>:</italic> Among children suffering from inherited epidermolysis bullosa, confirmed food allergy was 13.9% of cases (in 13.4% in the group of children with dystrophic form of the disease, 15.2% in the group of children with a simple form of the disease). The main manifestations of food allergy in this cohort of patients were skin symptoms. Cow’s milk proteins were the most frequent etiological factor of food allergy (78.3%). Most children with food allergies had a high level of total IgE (87.5%). In children with non-IgE mediated form, high levels of total IgE were detected in 25% of cases, while these children were characterized by a severe course of the underlying disease or the presence of concomitant atopic dermatitis. Burdened heredity for allergic diseases turned out to be more typical for children with an IgE-mediated form of food allergy from the group of simple epidermolysis bullosa.</p> <p><bold><italic>CONCLUSION</italic></bold><italic>:</italic> Early detection of food allergies in children with inherited epidermolysis bullosa, as an aggravating factor in the course of the underlying disease, is necessary to optimize the tactics of dietary support for patients with inherited epidermolysis bullosa.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование</bold>. Врождённый буллёзный эпидермолиз ― тяжёлое орфанное наследственное заболевание с преимущественным поражением кожи и слизистых оболочек. Изучение коморбидного фона, в том числе пищевой аллергии, остаётся актуальным вопросом, учитывая нередко возникающие трудности в лечении и формировании рациона у данной категории больных.</p> <p><bold>Цель</bold> ― оценить частоту встречаемости и характер пищевой аллергии у детей с врождённым буллёзным эпидермолизом.</p> <p><bold>Материалы и методы</bold>. В открытое одноцентровое нерандомизированное наблюдательное ретроспективно-проспективное исследование было включено 165 пациентов в возрасте от 2 месяцев до 17 лет с диагнозом врождённого буллёзного эпидермолиза. Всем пациентам проводились оценка аллергологического анамнеза, определение уровней общего IgE и аллергенспецифических IgE сыворотки крови к наиболее значимым пищевым аллергенам (UniCAP System, Thermo Fisher Scientific), при необходимости назначались диагностическая элиминационная диета и диагностическое введение продукта, а на основании полученных данных подтверждался или исключался диагноз пищевой аллергии.</p> <p><bold>Результаты</bold>. Среди детей с врождённым буллёзным эпидермолизом подтверждённая пищевая аллергия составила 13,9% случаев (13,4% в группе с дистрофической, 15,2% в группе с простой формой заболевания). Основными проявлениями пищевой аллергии в данной когорте больных были кожные симптомы. Наиболее частым этиологическим фактором пищевой аллергии выступали белки коровьего молока (78,3%). Большинство детей с пищевой аллергией имели высокий уровень общего IgE (87,5%). У детей с не-IgE-опосредованной формой высокие уровни общего IgE выявлялись в 25% случаев, и для этих пациентов было характерно тяжёлое течение основного заболевания и/или наличие сопутствующего атопического дерматита. Отягощённая наследственность по аллергическим заболеваниям оказалась более характерна для детей с IgE-опосредованной формой пищевой аллергии из группы простого буллёзного эпидермолиза.</p> <p><bold>Заключение</bold>. Раннее выявление пищевой аллергии как отягчающего фактора течения основного заболевания необходимо для оптимизации тактики диетологического сопровождения больных с врождённым буллёзным эпидермолизом.</p></trans-abstract><kwd-group xml:lang="en"><kwd>inherited epidermolysis bullosa</kwd><kwd>food allergy</kwd><kwd>food sensitization</kwd><kwd>children</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>врождённый буллёзный эпидермолиз</kwd><kwd>пищевая аллергия</kwd><kwd>пищевая сенсибилизация</kwd><kwd>дети</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Mariath LM, Santin JT, Schuler-Faccini L, Kiszewski AE. Inherited epidermolysis bullosa: update on the clinical and genetic aspects. An Bras Dermatol. 2020;95(5):551–569. doi: 10.1016/j.abd.2020.05.001</mixed-citation><mixed-citation xml:lang="ru">Mariath L.M., Santin J.T., Schuler-Faccini L., Kiszewski A.E. Inherited epidermolysis bullosa: Update on the clinical and genetic aspects // An Bras Dermatol. 2020. Vol. 95, N 5. Р. 551–569. doi: 10.1016/j.abd.2020.05.001</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry. JAMA Dermatol. 2016;152(11): 1231–1238. doi: 10.1001/jamadermatol.2016.2473</mixed-citation><mixed-citation xml:lang="ru">Fine J.D. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry // JAMA Dermatol. 2016. Vol. 152, N 11. Р. 1231–1238. doi: 10.1001/jamadermatol.2016.2473</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Has C, Fischer J. Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes // Exp Dermatol. 2019. Vol. 28. N 10. Р. 1146–1152. doi: 10.1111/exd.13668</mixed-citation><mixed-citation xml:lang="ru">Has C., Fischer J. Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes // Exp Dermatol. 2019. Vol. 28, N 10. Р. 1146–1152. doi: 10.1111/exd.13668</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Epidermolysis bullosa: A guide for doctors. Ed. by N.N. Murashkin, L.S. Namazova-Baranova. Moscow: Pediatr; 2019. 443 р. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Буллезный эпидермолиз: руководство для врачей / под ред. Н.Н. Мурашкина, Л.С. Намазовой-Барановой. Москва: ПедиатрЪ, 2019. 443 с.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">So JY, Joyce T. Epidermolysis bullosa simplex. In: GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993. [updated 2022 Aug 4].</mixed-citation><mixed-citation xml:lang="ru">So J.Y., Joyce T. Epidermolysis bullosa simplex. In: GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993. [updated 2022 Aug 4].</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Atherton D, Denyer J. Epidermolysis bullosa: An outline for professionals. DebRA, Berkshire; 2002. Р. 37–71.</mixed-citation><mixed-citation xml:lang="ru">Atherton D., Denyer J. Epidermolysis bullosa: An outline for professionals. DebRA, Berkshire, 2002. Р. 37–71.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Horn HM, Tidman MJ. Quality of life in epidermolysis bullosa. Clin Exp Dermatol. 2002;27(8):707–710. doi: 10.1046/j.1365-2230.2002.01121.x</mixed-citation><mixed-citation xml:lang="ru">Horn H.M., Tidman M.J. Quality of life in epidermolysis bullosa // Clin Exp Dermatol. 2002. Vol. 27, N 8. Р. 707–710. doi: 10.1046/j.1365-2230.2002.01121.x</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Bachir Y, Daruich A, Marie C, et al. Eye involvement and management in inherited epidermolysis bullosa. Drugs. 2022;82(12):1277–1285. doi: 10.1007/s40265-022-01770-8</mixed-citation><mixed-citation xml:lang="ru">Bachir Y., Daruich A., Marie C., et al. Eye involvement and management in inherited epidermolysis bullosa // Drugs. 2022. Vol. 82, N 12. Р. 1277–1285. doi: 10.1007/s40265-022-01770-8</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Epishev RV. Nutritional support for children with congenital epidermolysis bullosa. [dissertation abstract]. Moscow; 2018. 26 р. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Епишев Р.В. Нутритивная поддержка детей c врожденным буллезным эпидермолизом: Автореф. дис. … канд. мед. наук. Москва, 2018. 26 с.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Papanikolaou M, Onoufriadis A, Mellerio JE, et al. Prevalence, pathophysiology and management of itch in epidermolysis bullosa. Br J Dermatol. 2021;184(5):816–825. doi: 10.1111/bjd.19496</mixed-citation><mixed-citation xml:lang="ru">Papanikolaou M., Onoufriadis A., Mellerio J.E., et al. Prevalence, pathophysiology and management of itch in epidermolysis bullosa // Br J Dermatol. 2021. Vol. 184, N 5. Р. 816–825. doi: 10.1111/bjd.19496</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Nakashima C, Ishida Y, Kitoh A, et al. Interaction of peripheral nerves and mast cells, eosinophils, and basophils in the development of pruritus. Exp Dermatol. 2019;28(12):1405–1411. doi: 10.1111/exd.14014</mixed-citation><mixed-citation xml:lang="ru">Nakashima C., Ishida Y., Kitoh A., et al. Interaction of peripheral nerves and mast cells, eosinophils, and basophils in the development of pruritus // Exp Dermatol. 2019. Vol. 28, N 12. Р. 1405–1411. doi: 10.1111/exd.14014</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Steinhoff M, Schmelz M, Szabó IL, Oaklander AL. Clinical presentation, management, and pathophysiology of neuropathic itch. Lancet Neurol. 2018;17(8):709–720. doi: 10.1016/S1474-4422(18)30217-5</mixed-citation><mixed-citation xml:lang="ru">Steinhoff M., Schmelz M., Szabó I.L., Oaklander A.L. Clinical presentation, management, and pathophysiology of neuropathic itch // Lancet Neurol. 2018. Vol. 17, N 8. Р. 709–720. doi: 10.1016/S1474-4422(18)30217-5</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Chen F, Guo Y, Zhou K, et al. The clinical efficacy and safety of anti-IgE therapy in recessive dystrophic epidermolysis bullosa. Clin Genet. 2022;101(1):110–115. doi: 10.1111/cge.14062</mixed-citation><mixed-citation xml:lang="ru">Chen F., Guo Y., Zhou K., et al. The clinical efficacy and safety of anti-IgE therapy in recessive dystrophic epidermolysis bullosa // Clin Genet. 2022. Vol. 101, N 1. Р. 110–115. doi: 10.1111/cge.14062</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Makarova SG, Namazova-Baranova LS, Murashkin NN, et al. Food allergy in children with inherited epidermolysis bullosa. The results of the observational study. Ann Russ Academy Medical Sciences. 2018;73(1):49–58. (In Russ). doi: 10.15690/vramn847</mixed-citation><mixed-citation xml:lang="ru">Макарова С.Г., Намазова-Баранова Л.С., Мурашкин Н.Н., и др. Пищевая аллергия у детей с врожденным буллезным эпидермолизом. Результаты собственного наблюдательного исследования // Вестник РАМН. 2018. № 1. С. 49–58. doi: 10.15690/vramn847</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Saraiya A, Yang CS, Kim J, et al. Dermal eosinophilic infiltrate in junctional epidermolysis bullosa. J Cutan Pathol. 2015;42(8): 559–563. doi: 10.1111/cup.12521</mixed-citation><mixed-citation xml:lang="ru">Saraiya A., Yang C.S., Kim J., et al. Dermal eosinophilic infiltrate in junctional epidermolysis bullosa // J Cutan Pathol. 2015. Vol. 42, N 8. Р. 559–563. doi: 10.1111/cup.12521</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Izadi N, Luu M, Ong Y., Tam JS. The role of skin barrier in the pathogenesis of food allergy. Children (Basel). 2015;2(3):382–402. doi: 10.3390/children2030382</mixed-citation><mixed-citation xml:lang="ru">Izadi N., Luu M., Ong P.Y., Tam J.S. The role of skin barrier in the pathogenesis of food allergy // Children (Basel). 2015. Vol. 2, N 3. Р. 382–402. doi: 10.3390/children2030382</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Clinical recommendations. Inherited bullous epidermolysis. Moscow; 2020. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Врожденный буллезный эпидермолиз. Клинические рекомендации. Москва, 2020.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Muraro A, Roberts G, Worm M, et al. Anaphylaxis: Guidelines from the European academy of allergy and clinical immunology. Allergy. 2014;69(8):1026–1045. doi: 10.1111/all.12437</mixed-citation><mixed-citation xml:lang="ru">Muraro A., Roberts G., Worm M., et al. Anaphylaxis: Guidelines from the European academy of allergy and clinical immunology // Allergy. 2014. Vol. 69, N 8. Р. 1026–1045. doi: 10.1111/all.12437</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Clinical recommendations. Food allergy. The Union of Pediatricians of Russia; 2021. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Пищевая аллергия. Клинические рекомендации. Союз педиатров России, 2021.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Freeman EB, Köglmeier J, Martinez AE, et al. Gastrointestinal complications of epidermolysis bullosa in children. Br J Dermatol. 2008;158(6):1308–1314. doi: 10.1111/j.1365-2133.2008.08507.x</mixed-citation><mixed-citation xml:lang="ru">Freeman E.B., Köglmeier J., Martinez A.E., et al. Gastrointestinal complications of epidermolysis bullosa in children // Br J Dermatol. 2008. Vol. 158, N 6. Р. 1308–1314. doi: 10.1111/j.1365-2133.2008.08507.x</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Galimova AA, Makarova SG, Murashkin NN, Snovskaya MA. Comorbid food allergy in patients with congenital epidermolysis bullosa. Med Alphabet. 2023;(8):82–85. (In Russ). doi: 10.33667/2078-5631-2023-8-82-85</mixed-citation><mixed-citation xml:lang="ru">Галимова А.А., Макарова С.Г., Мурашкин Н.Н., Сновская М.А. Коморбидная пищевая аллергия у пациентов с врожденным буллезным эпидермолизом // Медицинский алфавит. 2023. № 8. С. 82–85. doi: 10.33667/2078-5631-2023-8-82-85</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Schoemaker AA, Sprikkelman AB, Grimshaw KE, et al. Incidence and natural history of challenge-proven cow’s milk allergy in European children: EuroPrevall birth cohort. Allergy. 2015;70(8): 63–972. doi: 10.1111/all.12630</mixed-citation><mixed-citation xml:lang="ru">Schoemaker A.A., Sprikkelman A.B., Grimshaw K.E., et al. Incidence and natural history of challenge-proven cow’s milk allergy in European children: EuroPrevall birth cohort // Allergy. 2015. Vol. 70, N 8. Р. 963–972. doi: 10.1111/all.12630</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Chen F, Guo Y, Zhou K, et al. The clinical efficacy and safety of anti-IgE therapy in recessive dystrophic epidermolysis bullosa. Clin Genet. 2022;101(1):110–115. doi: 10.1111/cge.14062</mixed-citation><mixed-citation xml:lang="ru">Chen F., Guo Y., Zhou K., et al. The clinical efficacy and safety of anti-IgE therapy in recessive dystrophic epidermolysis bullosa // Clin Genet. 2022. Vol. 101, N 1. Р. 110–115. doi: 10.1111/cge.14062</mixed-citation></citation-alternatives></ref></ref-list></back></article>
